A new tumor escape mechanism tuned by HHLA2

被引：0
|
作者：
Leau, R. [1 ]
Huchet, V. [1 ]
Neel, M. [1 ]
Gricourt, M. [1 ]
Blancho, G. [1 ]
Ville, S. [1 ]
Haspot, F. [1 ]
机构：
[1] CR2TI, UMR 1064, Nantes, France
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P175
引用
收藏
页码：168 / 168
页数：1
相关论文
共 50 条
  • [31] HHLA2 Expression Demonstrated by Immunohistochemistry in Non-Ductal Pancreatic Tumors
    de Gonzalez, Anne K. Koehne
    Yan, Han
    Su, Gloria H.
    Remotti, Helen
    MODERN PATHOLOGY, 2018, 31 : 681 - 681
  • [32] HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families
    Janakiram, Murali
    Chinai, Jordan M.
    Zhao, Aimin
    Sparano, Joseph A.
    Zang, Xingxing
    ONCOIMMUNOLOGY, 2015, 4 (08):
  • [33] Interferon Gamma-Induced Interferon Regulatory Factor 1 Activates Transcription of HHLA2 and Induces Immune Escape of Hepatocellular Carcinoma Cells
    Wang, Rui
    Guo, Hui
    Tang, Xiaotong
    Zhang, Tiantian
    Liu, Yang
    Zhang, Cheng
    Yu, Hanbing
    Li, Yumei
    INFLAMMATION, 2022, 45 (01) : 308 - 330
  • [34] HHLA2 promotes tumor progression by long non-coding RNA H19 in human gallbladder cancer
    Zhang, Yizhou
    Li, Hanrong
    Lv, Chao
    Wu, Baokang
    Yu, Yang
    Zhong, Chongli
    Lang, Qi
    Liang, Zhiyun
    Li, Yang
    Shi, Yu
    Zhang, Jian
    Xu, Feng
    Tian, Yu
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 61 (03)
  • [35] HHLA2 overexpression is a novel biomarker of malignant status and poor prognosis in gastric cancer
    Li Wei
    Liang Tang
    Haiyan Chang
    Song Huo
    Yan Li
    Human Cell, 2020, 33 : 116 - 122
  • [36] HHLA2 overexpression is a novel biomarker of malignant status and poor prognosis in gastric cancer
    Wei, Li
    Tang, Liang
    Chang, Haiyan
    Huo, Song
    Li, Yan
    HUMAN CELL, 2020, 33 (01) : 116 - 122
  • [37] HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer
    Xu, Guocai
    Shi, Yuanyuan
    Ling, Xiaoting
    Wang, Dongyan
    Liu, Yunyun
    Lu, Huaiwu
    Peng, Yongpai
    Zhang, Bingzhong
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [38] RETRACTED: HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer (Retracted Article)
    Yang, Zeng
    Xu, Diao
    Ye, Xiao
    Lin, Xuehua
    Zhang, Min
    Su, Yan
    Xie, Qun
    Ni, Wenjun
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [39] KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy
    Li, Yang
    Lv, Chao
    Yu, Yang
    Wu, Baokang
    Zhang, Yizhou
    Lang, Qi
    Liang, Zhiyun
    Zhong, Chongli
    Shi, Yu
    Han, Shukun
    Xu, Feng
    Tian, Yu
    JOURNAL OF ADVANCED RESEARCH, 2023, 47 : 137 - 150
  • [40] HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer
    Guocai Xu
    Yuanyuan Shi
    Xiaoting Ling
    Dongyan Wang
    Yunyun Liu
    Huaiwu Lu
    Yongpai Peng
    Bingzhong Zhang
    Cancer Cell International, 21
12345